[C-peptide in the insulin-dependent diabetic].

Area of Science:

• Endocrinology
• Metabolic Diseases
• Diabetes Mellitus Research

Background:

• Distinguishing between classical insulin-dependent diabetes (Type 1) and non-insulin dependent diabetes (Type 2) progressing to insulin dependence is crucial.
• Understanding residual beta-cell function and insulin sensitivity is key in managing diabetes progression.

Purpose of the Study:

• To compare plasma C-peptide levels and insulin requirements in classical insulin-dependent diabetics versus those who became insulin-dependent after non-insulin dependent diabetes.
• To investigate potential differences in insulin resistance between these two groups of diabetic patients.

Main Methods:

• Measurement of plasma C-peptide levels in two groups of diabetic patients under insulin therapy.
• Assessment of metabolic control using blood glucose and glycosylated A1C haemoglobin levels.
• Comparison of insulin doses required for both patient groups.

Main Results:

• Group II patients (previously non-insulin dependent) had twice the C-peptide levels compared to Group I (classical insulin-dependent).
• Metabolic control and insulin doses were similar, though slightly higher in Group II.
• Higher C-peptide levels in Group II suggest greater endogenous insulin production or reduced insulin clearance, indicative of insulin resistance.

Conclusions:

• Patients transitioning from non-insulin dependent diabetes to insulin dependence exhibit higher insulin resistance than classical insulin-dependent diabetics.
• This increased insulin resistance may be linked to advanced age or the inherent characteristics of non-insulin dependent diabetes.
• Findings highlight the importance of assessing insulin sensitivity in long-term diabetes management.